Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults.
Boger
Rainer H
RH
D000208:Acute Disease; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D001682:Biological Availability; D004791:Enzyme Inhibitors / Q000097:blood; D000882:Haplorhini; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications* / Q000503:physiopathology*; D008715:Methionine / Q000378:metabolism; D009569:Nitric Oxide / Q000493:pharmacokinetics*; D018384:Oxidative Stress; D015203:Reproducibility of Results
D004791:Enzyme Inhibitors; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D001120:Arginine; D008715:Methionine